Skip to main content

Grafa News and Videos — Page 1087

Grafa Headlines

Latest

Grafa

Neurocrine reports positive data for INGREZZA in patients with IDD and tardive dyskinesia

Neurocrine Biosciences (NASDAQ:NBIX) has announced new clinician-reported data highlighting the effectiveness of INGREZZA (valbenazine) in treating tardive dyskinesia (TD) among individuals with intellectual and developmental disabilities (IDD).

Read more: Neurocrine reports positive data for INGREZZA in patients with IDD and tardive dyskinesia
Grafa
Technology

Alliance Resource Partners expands royalty portfolio with $206M acquisition

Alliance Resource Partners (NASDAQ:ARLP) announced on June 8, 2026, that it has entered into definitive agreements to acquire general partner and limited partner interests in AllDale Minerals III, LP and AllDale Minerals IV, LP (collectively, “AllDale III & IV”) for approximately $206.2 million.

Read more: Alliance Resource Partners expands royalty portfolio with $206M acquisition

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift